Tickers

PZZA — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-21 08:25:36.576986 UTC · finished 2026-09-21 08:33:37.594331 UTC

1. Composite Trajectory Verdict

Given PZZA's franchisor-heavy model with ongoing refranchising, restructuring, and technology investment, the income statement (profitability trends), cash flow statement (free cash flow generation), and balance sheet (leverage and liquidity) all carry roughly equal weight in assessing financial performance.

Composite Trajectory: Mixed

The annual income statement shows a sharp deterioration in 2025 (operating income -43% YoY, net income -62% YoY) after a modest improvement in 2024. Cash generation improved in 2025 versus 2024 (operating cash flow +18%, free cash flow +79%) but remained well below 2023 levels. The balance sheet shows debt reduction and a comfortable leverage ratio (3.2x vs 5.25x covenant) but a widening stockholders' deficit. These opposing moves — earnings decline versus cash flow recovery and debt reduction — produce a mixed overall trajectory.

2. Red Flags

  • Operating income collapsed 43% YoY to $89.1M in 2025 from $156.7M in 2024, while revenue was essentially flat (-0.3%) (10-K 2025-12-28, Consolidated Statements of Operations).
  • Net income fell 62% YoY to $32.1M in 2025 from $84.2M in 2024 (10-K 2025-12-28, Consolidated Statements of Operations).
  • G&A expenses surged 28% YoY to $244.3M in 2025, driven by $21.2M incremental marketing, $13.8M higher management incentive compensation, and a franchise conference (10-K 2025-12-28, MD&A – Costs and Expenses).
  • Depreciation & amortization jumped 33% YoY to $92.2M due to $18.4M accelerated depreciation on legacy technology; an additional $5–10M is expected in 2026 (10-K 2025-12-28, MD&A – Costs and Expenses; Critical Accounting Policies).
  • Restructuring charges of $7.7M were recognized in Q4 2025 for the Enterprise Transformation Plan; total estimated charges for approved actions are $24–31M (including the $7.7M) through 2027 (10-K 2025-12-28, MD&A – Recent Developments and Trends; Note 16).
  • International Transformation Plan completed with $34.4M total costs (approx. $20M cash) over its life (10-K 2025-12-28, MD&A – International Transformation Plan; Note 16).
  • Effective tax rate spiked to 33.6% in 2025 from 26.2% in 2024, primarily due to lower pretax income and tax shortfalls from restricted share vesting (10-K 2025-12-28, Consolidated Statements of Operations; MD&A – Income Tax Expense).
  • Allowance for credit losses on franchisee notes rose to $17.8M at year-end 2025 from $15.2M at year-end 2024 (10-K 2025-12-28, Note 10).
  • Valuation allowance on deferred tax assets increased to $48.2M from $44.5M (10-K 2025-12-28, Note 17).
  • No share repurchases in 2024 or 2025 despite $90.2M remaining authorization (10-K 2025-12-28, Note 6).
  • Free cash flow (non-GAAP) improved to $61.3M in 2025 from $34.1M in 2024 but the 2023 figure is not provided, limiting trend context (10-K 2025-12-28, MD&A – Free Cash Flow).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Revenue was nearly flat in 2025 (-0.3% YoY to $2.054B) after a 3.6% decline in 2024 (10-K 2025-12-28, Consolidated Statements of Operations). Operating income fell 43% YoY to $89.1M in 2025 after rising 6.5% in 2024 (10-K 2025-12-28, Consolidated Statements of Operations). Net income dropped 62% YoY to $32.1M in 2025 after a 1.7% increase in 2024 (10-K 2025-12-28, Consolidated Statements of Operations). The 2025 decline was driven by a 28% surge in G&A (marketing, incentives, conference), a 33% jump in depreciation (accelerated tech depreciation), and a higher effective tax rate (33.6% vs 26.2%). Comparable sales trends were negative in North America (-2.5% system-wide) but positive internationally (+5.0%) (10-K 2025-12-28, MD&A – Global Restaurant Sales). The conflicting YoY movements (2024 improvement, 2025 sharp decline) result in a mixed trajectory.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Operating cash flow dropped 45% in 2024 vs 2023 (to $106.6M from $193.1M) then recovered 18% in 2025 to $126.0M, still 35% below the 2023 level (10-K 2025-12-28, Consolidated Statements of Cash Flows). Free cash flow (non-GAAP) rose 79% YoY to $61.3M in 2025 from $34.1M in 2024 (10-K 2025-12-28, MD&A – Free Cash Flow). Investing outflows increased slightly to $21.5M in 2025 from $17.3M in 2024, reflecting $74.4M capex (including $9.7M disaster-related) partially offset by $34.5M refranchising proceeds (10-K 2025-12-28, Consolidated Statements of Cash Flows). Financing outflows rose to $106.3M in 2025 from $91.7M in 2024, driven by dividend payments ($61.1M) and net debt repayments ($27.7M) (10-K 2025-12-28, Consolidated Statements of Cash Flows). The recovery in 2025 operating and free cash flow after a steep 2024 decline yields a mixed trend.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Insufficient Data

Overall Assessment: Only two year-end balance sheets are provided (Dec 28, 2025 and Dec 29, 2024), preventing a multi-year trend analysis. Between those two dates, total assets fell 5.8% to $837.5M, total liabilities fell 2.5% to $1.270B, and the stockholders' deficit widened 4.7% to -$433.7M (10-K 2025-12-28, Consolidated Balance Sheets). Outstanding debt decreased 3.3% to $722.3M, and the leverage ratio stood at 3.2x (covenant 5.25x) with interest coverage at 3.2x (10-K 2025-12-28, MD&A – Liquidity and Capital Resources). Without the 2023 balance sheet, it is not possible to determine whether the 2024–2025 changes represent a continuation or reversal of a prior trend.

6. Data Gaps

  • Quarterly revenue, operating income, net income, and cash flows for Q1 2026, Q2 2026, Q3 2025, and Q2 2025 (require the 10-Q filings for those periods, which were listed but not provided in the document set).
  • Full 2023 balance sheet (require the 10-K for fiscal 2024 or 2023).
  • Free cash flow for 2023 (require 2023 10-K or explicit disclosure).
  • Comparable sales and unit growth data for quarterly periods (require 10-Q MD&A sections).
  • Leverage ratio and interest coverage ratio for 2024 (require 2024 10-K or credit agreement compliance disclosure).
  • Detailed segment profit trends for 2023 (require 2023 10-K segment note).
  • Impact of the 2025 refranchising transaction on future royalty streams (require subsequent filings).
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status